Conventional ablation therapies, which include the application of heat, chemical agents, or non-specific laser wavelengths, often struggle to discriminate between cancerous and normal pancreatic tissue. This lack of precision frequently leads to collateral damage, exacerbating post-operative complications and impairing organ function. Recognizing these limitations, Liang’s group sought a novel strategy that capitalizes on tumor-specific molecular characteristics to improve accuracy and safety. By identifying a laser wavelength precisely tuned to the collagen absorption peak within PDAC tumors, they developed a femtosecond mid-infrared laser system capable of selectively targeting the malignancy.

Central to this innovation is the utilization of a 6.1-micron wavelength laser, which aligns closely with the vibrational absorption bands of collagen fibers. Collagen is markedly overexpressed in PDAC tumor stroma compared to healthy pancreatic tissue, making it an ideal endogenous biomarker for selective targeting. Employing femtosecond pulses—ultrafast bursts of laser energy—maximizes the ablation effect while minimizing thermal diffusion, thereby preserving adjacent non-cancerous structures. This molecular resonance strategy, distinct from conventional photothermal ablation, leverages the intrinsic biochemical disparity between tumor and normal tissue to effect precise surgical intervention.

The team collaborated with experts from Nanyang Technological University to enhance clinical deliverability by incorporating an anti-resonant hollow-core fiber with an outer diameter under 400 microns. This cutting-edge fiber optic cable ensures efficient transmission of the mid-infrared laser light into the human body, with bending losses maintained below 1 dB/m even at clinically relevant curvature radii. Engineered for durability with biocompatible polyimide jackets and sapphire endcaps, the fiber facilitates minimally invasive access deep within the pancreatic region, overcoming major practical barriers to deploying mid-infrared laser therapy in vivo.

Extensive ex vivo experimentation on tumor samples obtained from 13 patients demonstrated that this wavelength-selective ablation method outperforms traditional non-resonant wavelengths, such as 1 or 3 microns, by two to three times in tumor destruction efficiency. Histological analyses confirmed substantial tumor eradication accompanied by remarkable preservation of normal pancreatic parenchyma. These findings suggest a substantial leap forward toward reducing the morbidity associated with standard surgical or thermal ablation approaches, which frequently compromise organ function and patient quality of life.

This technology’s clinical promise extends beyond improved efficacy; it holds the potential to fundamentally change the therapeutic landscape of pancreatic cancer by enabling safer, less invasive tumor resections. By sparing healthy tissue, this laser system could significantly curtail the risk of complications such as pancreatic fistula, infection, and exocrine or endocrine insufficiency. Moreover, its adaptability offers physicians a powerful tool to tailor treatments individually based on tumor molecular composition, marking a pioneering stride toward precision oncology modalities that extend well past current standards.

Future work aims to refine laser parameters and fiber configuration to optimize ablation depth, uniformity, and stability during clinical procedures. Integration with optical coherence tomography is underway to enable real-time imaging-guided tumor margin delineation and immediate therapeutic feedback. This combined diagnostic-therapeutic platform aspires to perform simultaneous cancer detection and ablation, potentially supporting intraoperative decision-making with unprecedented accuracy.

Beyond pancreatic cancer, this molecular resonance laser strategy could be adapted for other malignancies characterized by distinctive extracellular matrix compositions or molecular aberrations. Tumors rich in specific biomolecules might become amenable to similarly selective ablation, opening a new frontier in laser oncology where treatment specificity is dictated by intrinsic tissue biochemistry rather than extrinsic energy delivery parameters alone. Such an approach could fundamentally shift laser-assisted cancer therapy paradigms across diverse tumor types and anatomical locations.

Despite its profound potential, translation into clinical practice will require meticulous biological safety evaluations and rigorous clinical trials to establish long-term safety profiles, optimal dosing, and efficacy benchmarks. The research team emphasizes the need for structured studies that assess risks alongside therapeutic benefits to pave the way for regulatory approvals and widespread adoption. Refinement of the integrated laser and fiber delivery system also remains a priority to ensure ease of use, patient safety, and procedural reliability in operating rooms and endoscopy suites.

This pioneering research, published in the high-impact optics journal Optica, underscores the transformative role of photonics in modern medicine. By harnessing the specificity of molecular absorption signatures, this laser ablation technology exemplifies how interdisciplinary innovation at the junction of optics, engineering, and oncology can yield tangible clinical breakthroughs. As the relentless quest to tame pancreatic cancer continues, such advances bring hope for more effective, less invasive therapies that preserve life and improve outcomes for patients worldwide.

Selective tumor ablation using femtosecond mid-infrared lasers resonant with collagen represents a paradigm shift in targeted cancer therapy, emphasizing molecular fingerprinting to navigate the complexity of tumor biology. This work not only advances the state of the art in pancreatic cancer treatment but also sets a precedent for leveraging molecular resonances for precision tissue ablation in the future. By reducing collateral damage and enhancing treatment selectivity, it opens a promising path toward safer, minimally invasive surgical options that ultimately may save countless lives.

Subject of Research: Pancreatic ductal adenocarcinoma (PDAC) selective ablation using femtosecond mid-infrared laser technology targeting collagen molecular absorption.

Article Title: Selective tumor ablation via femtosecond laser resonant with collagen.

Web References:

• Optica Journal: https://opg.optica.org/optica/abstract.cfm?doi=10.1364/OPTICA.561337
• Sichuan University: https://en.scu.edu.cn/
• Nanyang Technological University: https://www.ntu.edu.sg/

References:
D. Zhang, X. Huang, X. Yang, N. Xia, K. Tian, J. Guo, M. Xiang, L. He, Z. Fu, A. Deng, H. Wu, Y. Wang, W. Chang, B. Tian, J. Xiong, Q. Wang, A. Gomes, H. Liang, “Selective tumor ablation via femtosecond laser resonant with collagen,” Optica, vol. 12, pp. 1578-1586, 2025. DOI: 10.1364/OPTICA.561337.

Image Credits: Houkun Liang, Sichuan University.

Keywords: Cancer research, pancreatic cancer, tumor ablation, femtosecond laser, mid-infrared laser, collagen targeting, selective tissue ablation, minimally invasive surgery, photonics in medicine, laser oncology, molecular fingerprinting, optical fiber delivery.

At the core of this innovation lies the generation of solitons—self-reinforcing, localized wave packets that maintain their shape as they propagate due to a balance between dispersion and nonlinear effects within the medium. While solitons are well-established in passive nonlinear Kerr resonators, such as silica microresonators, their realization inside active laser systems has posed significant challenges. The reported system ingeniously exploits a fast bistability inherent to active nonlinear laser resonators. Unlike traditional mode-locking techniques that rely on saturable absorbers or gain modulation, this laser chip leverages intrinsic nonlinearities within the active region itself. This subtle yet fundamental difference allows for the spontaneous formation of stable, bright solitons at GHz repetition rates without the complexity of external modulation or passive nonlinear elements.

This device comprises a monolithic integration of several key components on a single chip: the drive laser, an active ring resonator, a coupler, and a pump filter. Such integration ensures a compact footprint and turnkey operation, where bright solitons emerge and sustain themselves robustly for hours under continuous operation, all without requiring active stabilization. The implications of this extend beyond just device convenience—stability and reproducibility are notoriously difficult to achieve in short-pulse, mid-IR sources, particularly when traditional bulky mode-lockers or external stabilization apparatuses are involved. This chip’s autonomous nature may well pave the way for widespread adoption in commercial and industrial photonics applications.

One of the most compelling features of this system is its ability to generate pulses with durations on the order of one picosecond, centered precisely at 8.3 micrometers wavelength. This wavelength region is particularly rich in molecular absorption lines, which makes it extremely valuable for spectroscopic sensing of gases and chemicals, environmental monitoring, and even medical diagnostics. The generation of solitons in this spectral range on a semiconductor chip is unprecedented, breaking new ground that was previously thought inaccessible using conventional integrated photonics approaches. Manufacturing such devices in industrial laser foundries is fully compatible with standard fabrication protocols, promising scalability and cost-effectiveness essential for broad dissemination.

The physical mechanisms driving soliton formation in this active laser differ fundamentally from those in passive microresonators. In traditional Kerr resonators, solitons arise due to passive nonlinearities—chiefly the intensity-dependent refractive index modulation—balanced against intrinsic dispersion of the cavity. However, in the presented laser chip, active nonlinearities induced by gain saturation and refractive index changes at high carrier densities create a fast bistable response. This bistability enables a unique route to soliton formation that intrinsic saturable absorbers cannot achieve. This hybrid behavior effectively blends active and passive microresonator physics, unifying previously distinct paradigms within integrated photonics.

Further technical nuance lies in the laser chip’s architecture—a highly optimized active ring resonator that circulates light multiple times to enable nonlinear interaction strength adequate for soliton generation at remarkably low drive powers. The integrated coupler and pump filter serve critical roles in isolating the desired nonlinear dynamics and suppressing unwanted spectral components, ensuring pure and stable soliton emission. Such design intricacies underscore the meticulous craftsmanship in marrying semiconductor laser engineering with nonlinear dynamics, marking a milestone in photonic device innovation.

Operational stability is another salient highlight. Conventional mid-infrared pulse sources based on downconversion frequently suffer from thermal drifts, alignment sensitivity, and mode competition, severely limiting long-term operation without intervention. In contrast, the demonstrated device maintains bright soliton pulses continuously for hours, a testament to robust self-stabilization inherent in the active nonlinear architecture. This characteristic alone propels the technology into realms where high uptime, low maintenance, and device reliability are non-negotiable requisites—such as in field-deployable sensors and real-time chemical analyzers.

Beyond its immediate utility, this new platform invites a deeper understanding of laser dynamics and frequency comb physics. By bridging active semiconductor laser processes and passive Kerr resonator phenomena, researchers can explore novel regimes of nonlinear optics, frequency comb generation, and ultrafast dynamics that were inaccessible or impractical before. This convergence opens opportunities for tailoring nonlinear behavior via material engineering, geometry tuning, and drive conditions, potentially unlocking customizable pulse shaping and comb spectra directly on-chip.

The broader impact of this work touches various ambitious technological sectors. Mid-infrared photonics underpins crucial applications in security screening, breath analysis for health diagnostics, industrial process monitoring, and environmental surveillance. Traditionally, these fields have been constrained by the lack of compact, bright, stable, and inexpensive mid-IR sources. The ability to produce picosecond solitons from a semiconductor chip directly addresses these limitations, promising to democratize access and integration of mid-IR photonics into portable devices, drones, satellites, and handheld analyzers.

From a manufacturing standpoint, the compatibility of the reported device with existing industrial foundry workflows removes a critical bottleneck in transitioning from lab demonstrations to commercial products. This monolithic integration mirrors the semiconductor industry’s standards, enabling mass production, quality control, and reproducibility at scale. It markedly contrasts with conventional mid-IR laser technologies, which often require intricate assembly, specialized nonlinear crystals, or cryogenic environments. This breakthrough marks an inflection point where mid-IR frequency combs leap from experimental curiosities to practical workhorse instruments.

Looking forward, the research community anticipates rapid developments, including extending spectral coverage deeper into the long-wave infrared, engineering multi-soliton states for high comb line counts, and integrating detection and signal processing modules on the same chip. The underlying physical principles demonstrated hint at a versatile platform adaptable to other wavelength regimes, potentially inspiring a new generation of chip-scale frequency combs across the electromagnetic spectrum. Such innovations will likely catalyze interdisciplinary applications—for instance, in quantum photonics, telecommunications, and ultrafast spectroscopy—beyond the immediate mid-infrared focus.

In summary, the realization of bright, stable, picosecond solitons directly from a DC-driven semiconductor laser chip marks a paradigm shift in mid-infrared photonics. It elegantly combines state-of-the-art integrated laser design, nonlinear optics, and material science to overcome longstanding obstacles in spectral coverage, pulse duration, device complexity, and stability. This technology promises not just incremental progress but a new chapter where mid-IR ultrafast photonics become scalable, accessible, and sustainably manufacturable, fostering innovations that reverberate across science, industry, and everyday technology.

Subject of Research: Mid-infrared integrated photonics; semiconductor laser solitons; nonlinear optics; frequency combs.

Article Title: Driven bright solitons on a mid-infrared laser chip.

Article References:
Kazakov, D., Letsou, T.P., Piccardo, M. et al. Driven bright solitons on a mid-infrared laser chip. Nature (2025). https://doi.org/10.1038/s41586-025-08853-y

Image Credits: AI Generated